CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 55.97 USD -0.5% Market Closed
Market Cap: 5.3B USD

Wall Street
Price Targets

CRSP Price Targets Summary
CRISPR Therapeutics AG

Wall Street analysts forecast CRSP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRSP is 80 USD with a low forecast of 32.32 USD and a high forecast of 281.4 USD.

Lowest
Price Target
32.32 USD
42% Downside
Average
Price Target
80 USD
43% Upside
Highest
Price Target
281.4 USD
403% Upside
CRISPR Therapeutics AG Competitors:
Price Targets
SOBI
Swedish Orphan Biovitrum AB (publ)
14% Upside
688177
Bio-Thera Solutions Ltd
64% Upside
FDMT
4D Molecular Therapeutics Inc
193% Upside
300142
Walvax Biotechnology Co Ltd
35% Downside
ACLX
Arcellx Inc
72% Upside
BSLN
Basilea Pharmaceutica AG
51% Upside
145020
Hugel Inc
70% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
100% Upside

Revenue
Forecast

Revenue Estimate
CRISPR Therapeutics AG

For the last 9 years the compound annual growth rate for CRISPR Therapeutics AG's revenue is 79%. The projected CAGR for the next 4 years is 118%.

79%
Past Growth
118%
Estimated Growth
Estimates Accuracy
13%
Average Beat

Operating Income
Forecast

Operating Income Estimate
CRISPR Therapeutics AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
CRISPR Therapeutics AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRSP's stock price target?
Price Target
80 USD

According to Wall Street analysts, the average 1-year price target for CRSP is 80 USD with a low forecast of 32.32 USD and a high forecast of 281.4 USD.

What is CRISPR Therapeutics AG's Revenue forecast?
Projected CAGR
118%

For the last 9 years the compound annual growth rate for CRISPR Therapeutics AG's revenue is 79%. The projected CAGR for the next 4 years is 118%.

Back to Top